Company: DMAAR
Filing Date: 2025-01-30
Form Type: 8-K
Source: 0001213900-25-008377
Chunk: 0

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-01-30
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01. Entry into
a Material Definitive Agreement.

On January 7, 2025,
the registration statement (File No. 333-281170) relating to the initial public offering (“ IPO”) of Drugs Made In
America Acquisition Corp. (the “ Company”) was declared effective by the Securities and Exchange Commission (the
“ Commission”) and the post-effective amendment to the registration statement was declared effective by the Commission on
January 27, 2025 (together, the “ Registration Statement”). In connection therewith, the Company entered into the following agreements, forms of which were previously filed
as exhibits to the Registration Statement:

  Underwriting Agreement, dated January 27, 2025, by and between the Company and Clear Street LLC, as representative  
  of the underwriters;                                                                                                
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Rights Agreement, dated January 7, 2025, by and between the Company and VStock Transfer, LLC;  
 ─────────────────────────────────────────────────────────────────────────────────────────────────

  Letter Agreement, dated January 7, 2025, by and among the Company, Drugs Made In America Acquisition LLC  
  (the “ Sponsor”), the initial shareholders and the officers and directors of the Company;                 
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Investment Management Trust Agreement, dated January 7, 2025, by and among the Company, Wilmington Trust  
  National Association and VStock Transfer, LLC;                                                            
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Registration Rights Agreement, dated January 7, 2025, by and among the Company and certain security holders  
  of the Company;                                                                                              
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Amended and Restated Private Units Subscription Agreement, dated January 27, 2025, by and between the  
  Company and the Sponsor;                                                                               
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────

  Indemnity Agreements, dated January 7, 2025, by and between the Company and each of the officers and directors  
  of the Company; and                                                                                             
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Administrative                                                                                                          
  Services Agreement, dated